Nose Neoplasms: Clinical Trials

4 trials for Nose Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 recruiting, 1 terminated. 4 Phase 1, 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 2, Recruiting 1, Terminated 1
Phase 24Completed 2, Recruiting 1, Terminated 1

Follow Nose Neoplasms: new trials by email Literature Review of Nose Neoplasms trials Research Report on Nose Neoplasms

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer
SX-682, DTX - Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma
Phase 1 / Phase 2RecruitingNational Cancer Institute (NCI)1202026-11-182026-11-13
Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)
Tabelecleucel, Pembrolizumab - Nasopharyngeal Carcinoma, Nasopharyngeal Neoplasms
Phase 1 / Phase 2TerminatedAtara Biotherapeutics122019-02-192024-11-14
Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer.
placebo, laboratory biomarker analysis, questionnaire administration - Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma, Salivary Gland Squamous Cell Carcinoma
Phase 1 / Phase 2CompletedOhio State University Comprehensive Cancer Center702007-09-042020-02-20
Erlotinib, Celecoxib and Reirradiation for Recurrent Head and Neck Cancer
erlotinib + celecoxib - Cancer of the Pharynx, Cancer of the Larynx
Phase 1 / Phase 2CompletedJohnny Kao152007-02-012017-04-10

Narrower conditions

Head and Neck Neoplasms (3)  ·  Laryngeal Neoplasms (3)  ·  Paranasal Sinus Neoplasms (3)  ·  Carcinoma (2)  ·  Hypopharyngeal Neoplasms (2)  ·  Nasopharyngeal Carcinoma (2)  ·  Nasopharyngeal Neoplasms (2)  ·  Pharyngeal Neoplasms (2)  ·  Salivary Gland Neoplasms (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Carcinoma, Adenoid Cystic (1)  ·  Epstein-Barr Virus Infections (1)  ·  Mouth Neoplasms (1)  ·  Nasopharyngeal Diseases (1)  ·  Neoplasms (1)

Broader conditions

Nose Diseases (4)  ·  Respiratory Tract Diseases (4)  ·  Respiratory Tract Neoplasms (4)  ·  Laryngeal Diseases (3)  ·  Neoplasms (3)  ·  Neoplasms by Site (3)  ·  Otorhinolaryngologic Diseases (3)  ·  Otorhinolaryngologic Neoplasms (3)  ·  Paranasal Sinus Diseases (3)  ·  Pharyngeal Diseases (3)  ·  Stomatognathic Diseases (3)  ·  Carcinoma, Squamous Cell (2)  ·  Mouth Diseases (2)  ·  Nasopharyngeal Diseases (2)

Interventions

Celecoxib (1)  ·  Chemoprevention (1)  ·  Erlotinib Hydrochloride (1)  ·  pembrolizumab (1)

Sponsors

Atara Biotherapeutics (1)  ·  Johnny Kao (1)  ·  National Cancer Institute (NCI) (1)  ·  Ohio State University Comprehensive Cancer Center (1)

Countries

United States (4)

Top investigators

Aditi Mehta, DO (1)  ·  Amit Agrawal (1)  ·  Charalampos Floudas, M.D. (1)  ·  Johnny Kao, M.D. (1)

Results publications

PMID 21246519